SolicitationActiveSPE2D2-21-R-0105
Bupropion HCL ER
DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY / DLA TROOP SUPPORTKey dates?
- Posted?
- Sep 15, 2025
- Response deadline?
- Feb 15, 2022, 8:00 PM UTC
- Archive date?
- —
- Archive type?
- autocustom
Classification?
- Notice type?
- Solicitation
- Base type?
- Solicitation
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- 6505
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE LOGISTICS AGENCY
- Office?
- DLA TROOP SUPPORT
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- PHILADELPHIA, PA, 19111, USA
Contacts?
- Kyle Lewickiprimary
- Jason C. Wraysecondary
Description?
Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. BUPROPION HCL ER NATIONAL CONTRACTS SOLICITATION
Other notices in this solicitation?
- SolicitationBupropion HCL ERSep 13, 2024
- SolicitationBupropion HCL ERMar 1, 2022
- SolicitationBupropion HCL ERFeb 8, 2022
- SolicitationBupropion HCL ERJan 11, 2022
Similar open contracts
Metadata?
- Notice ID?
- d2713ea231544d89b653a39e3fbe278e
- Full path?
- DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
- Office code?
- —
- Ingested?
- May 2, 2026
- Updated?
- Jul 11, 2026